Home > About > Our Board Sub Committees

Our Board Sub Committees

Centenary Commercialisation Committee

Dr C Glenn Begley
M.B., B.S., Ph.D., F.R.A.C.P., F.R.C.P.A., F.R.C.Path., F.A.H.M.S.

Dr Begley currently advises several biotechnology companies, academic groups and served as Chief Scientific Officer at two small biotechnology companies, From 2002-2012, he was Vice-President and Global Head of Hematology/Oncology Research at Amgen, responsible for building, directing and integrating Amgen’s 5 research sites. During this time he became interested in the issue of research integrity and scientific reproducibility. Before joining Amgen he had over 20 years of clinical experience in medical oncology and hematology.

He is Board Certified in Australia as a Medical Oncologist and Hematologist, has a PhD in cellular and molecular biology.


Assoc Prof Mark Gorrell
Associate Professor Mark Gorrell heads the Molecular Hepatology Laboratory in the Liver Injury and Cancer Program. He trained in cell biology, virology, immunology and protein biochemistry at Australian National University, University of Melbourne and Johns Hopkins University. His research is focussed upon liver cancer prevention and treatment, chronic liver disease pathogenesis, diabetes, protein and enzyme biochemistry and cell biology related to the proteases DPP4, DPP9 and fibroblast activation protein (FAP).

He has authored over 130 publications attracting H index 40, i10 index 81 and > 5,000 citations. His research experience also includes small RNA viruses, transcriptomics, proteomics and cell biology. His research was important in the development of DPP4-targetted therapies for type 2 diabetes, which are now used to treat millions of patients.

Inside Centenary Institute, he chairs the postgraduate research and equipment grants committees, is Sub-Dean for postgraduate research and a Commercialisation Committee member. Outside Centenary Institute, he is active in the International Proteolysis Society, the Gastroenterological Society of Australia, NHMRC grant reviews, and editorial boards of Journals including Scientific Reports.


Mr Bruce Grey
Mr Bruce Grey is currently Chairman of Advanced Braking Technology Limited listed on the Australian Stock Exchange, and he is a Non-Executive Director of CAP XX Limited listed on the London Stock Exchange.

He is currently a Board member of the Murdoch Children’s Research Institute and is also Chairman of the Translation and Commercialisation Committee. He is also a member of the Finance Risk and Audit Committee.

He is also a Board member of the Victorian Clinical Genetics Services a subsidiary of the Murdoch Children’s Research Institute.

For 10 years until 2009, was Chairman of a German JV between Bishop and Mercedes-Benz Lenkungen GmbH.

He has more than 20 years experience in managing industry R&D and more than 30 years experience in international commercialisation of Australian innovation. Over this period he also negotiated licence agreements in Japan, China, South Korea and the US yielding in excess of $100 million in royalties and licence fees.

In 2016 he became Chairman of the Industry Advisory Network for the University of New South Wales, School of Mechanical and Manufacturing Engineering.He is a Fellow of the Academy of Technological Scientists and Engineers and a Member of the Australian Institute of Company Directors.


Mr Jamie Nettleton
Jamie Nettleton is a partner in the Intellectual Property group at Addisons Lawyers in Sydney.  Jamie has practised law in both Sydney and London and has advised extensively in respect of the recognition, protection and exploitation of intellectual property rights, particularly in respect of new technologies.  He has a particular interest in the field of medical research and taking advantage of the opportunities that intellectual property rights afford.


Professor John Rasko
In addition to leading the Gene and Stem Cell Therapy Program at The Centenary Institute, Professor John Rasko AO is a clinical hematologist, pathologist and scientist with a productive track record in gene and stem cell therapy, experimental haematology and molecular biology. In over 150 publications he has contributed to the understanding of stem cells and haemopoiesis, gene transfer technologies, oncogenesis, human aminoacidurias and non-coding RNAs.

He serves on Hospital, state and national bodies including Chair of GTTAC, Office of the Gene Technology Regulator – responsible for regulating all genetically-modified organisms in Australia – and Chair of the Advisory Committee on Biologicals, Therapeutic Goods Administration. Contributions to scientific organisations include co-founding (2000) and past-President (2003-5) of the Australasian Gene Therapy Society; Vice President, International Society for Cellular Therapy (2008-12) and founder (2009) ISCT-Australia; Scientific Advisory Committees and Board member for philanthropic foundations; and several Ethics Committees. He is the recipient of national (RCPA, RACP, ASBMB) and international awards in recognition of his commitment to excellence in medical research, including appointment as an Officer of the Order of Australia.


Dr Chris Roberts
BE (Hons), PhD, Hon DSc (UNSW), MBA, Hon DSc (Macq), FAICD, FTSE, FIEAust

Dr Roberts is the former CEO of Cochlear Limited. Director of ResMed Inc since 1992 and Chairman of Research Australia (2004 – 2010). Dr Roberts has worked in the medical device industry for over 40 years in a number of senior management positions.


Centenary Investment Committee

Mr Paul Chadwick
Paul is a director and founder of Nanuk Asset Management, a Sydney based firm founded in late 2009 that specializes in global investments related to environmental sustainability.  Nanuk invests in listed companies that benefit from or contribute to greater sustainability and improved resource efficiency.  This ‘smart growth” includes clean energy, energy efficiency, water, waste management, pollution control and and agricultural productivity, as well as developments in industrial efficiency like automation, additive manufacturing and advanced transport. 

Previously, Paul was the Managing Director of GMO Australasia where, until retirement in mid 2008, he was the head of systematic global macro strategies as well as having responsibility for the overall management of the firm’s Australian and Singaporean operations. Prior to GMO, he held senior roles in global tactical asset allocation and derivatives trading at Westpac Investment Management and, earlier, senior positions in equity derivatives and quantitative analysis at the stockbroking firm James Capel Australia.  His career in finance has followed approximately ten years in aeronautical engineering and airline management in the USA and Australia respectively.

Paul holds degrees in Science and Aeronautical Engineering from the University of Sydney and is the current Chairman of AIMA Australia.


Mr Alastair Davidson
Mr Davidson has held executive positions in the banking and financial services industry for over 30 years in the UK, US and Australia and is a member of the Institute of Chartered Accountants in Scotland.

He is an Executive of Australasian Wealth Limited, a listed asset manager in Sydney.


Mr Tim Ryan
Mr Ryan is a director and Chairman of the Investment Committee at Nanuk Asset Management and Chairman of Orion Asset Management. He founded Orion in 2002 and has over 36 years’ professional investment industry experience.

Prior to Orion, Mr Ryan was Chief Investment Officer and a managing director at Credit Suisse Asset Management for seven years and earlier held various research and investment management roles including seven years at James Capel Australia where he was Head of Research and a Member of the Australian Stock Exchange.

Mr Ryan is a qualified accountant and holds an Economics degree from the University of Sydney.


Professor Mathew Vadas AO FAHMS
Professor Vadas followed his medical training with a PhD at the Walter and Eliza Hall Institute in Melbourne and postdoctoral work at Harvard.

He was the Inaugural Director of the Hanson Centre for Cancer Research (now Hanson Institute) in Adelaide and has been the Executive Director of Centenary Institute since 2007.


Centenary Risk and Audit Committee

Mr Michael  Coleman
Michael Coleman is an experienced director and Chairman. He is a pragmatic risk manager and Audit Committee expert specialising in financial services, property, funds management and media.

Michael is a non-executive director and Chairman of the Audit Committee at Macquarie Group Limited; a member of the Audit Committee of the Reserve Bank of Australia; Director and Chairman of Audit Committee at Legal Aid NSW; Adjunct Professor of Business, UNSW; National Board member and Chairman of Audit Committee and NSW Councillor of Australian Institute of Company Directors, Chairman of Planet Ark Environmental Foundation; Director of Osteoporosis Australia; member of the advisory board of Bingo Industries Limited. Michael retired from KPMG on 1 July 2011 after a 40-year career which included 30 years as a partner, executive experience as National Managing Partner for both Audit and Risk Management & Regulation in Australia and head of risk and regulatory management across Asia. As an audit partner Michael had extensive financial reporting and corporate governance experience across a range of industry sectors, but especially banking & finance, funds management, property and media in addition to significant government and regulatory engagement. He was Chairman of ING Management Limited and Chairman of the Financial Reporting Council.


Mr Alastair Davidson
Mr Davidson has held executive positions in the banking and financial services industry for over 30 years in the UK, US and Australia and is a member of the Institute of Chartered Accountants in Scotland.

He is an Executive of Australasian Wealth Limited, a listed asset manager in Sydney.


Ms Elizabeth Dibbs
Ms Dibbs held senior legal positions throughout her career, including General Counsel of PricewaterhouseCoopers prior to her retirement.

Ms Dibbs now focuses her energy on the government and not-for-profit sectors.

She is Deputy Chancellor of Western Sydney University and Chair of its Audit & Risk Committee, Chairman of United Way Australia and a member of Chief Executive Women.


Mr Peter Sutherland
Peter Sutherland has over 30 years experience in financial services, both in Australia and overseas, principally the United Kingdom and United States.

Peter has held senior risk management, compliance and audit roles in the Commonwealth Bank of Australia (CBA) and Insurance Australia Group, and was Chief Risk Officer of Colonial First State from 2009 to 2014. Most recently he has led conduct programs within CBA’s Wealth Management business unit and coordinated the work of independent experts engaged by the CommInsure business. During his eight years at CBA Peter was a member of and chaired a number of subsidiary CBA boards and board committees. He has extensive experience in working in highly regulated environments.

Prior to joining the commercial sector Peter worked with PriceWaterhouseCoopers for 13 years, in audit, due diligence and consulting roles.

Peter is a Chartered Accountant and Graduate of the Australian Institute of Company Directors and has post-graduate qualifications in risk management. He was an adviser to the Audit Committee of Reconciliation Australia.


Centenary Foundation Committee

Mr Joseph Carrozzi
Mr Carrozzi is a Managing Partner at PricewaterhouseCoopers (PwC).

He is admitted as a Barrister at Law in NSW, a Fellow of the Institute of Chartered Accountants in Australia and a Fellow of the Tax Institute of Australia.

Joseph is also Chairman of Australia’s Italian Chamber of Commerce and Industry, and Vice Chairman of the GWS Giants and sits on the boards of the NSW Institute of Sport and the Sydney Harbour Federation Trust.


Ms Suanne Colley
Bio coming soon.


Ms Julie Connolly
Julie has extensive community and stakeholder relations experience in both corporate and agency roles over three decades. She sits on several boards in the education and social services sector and is a passionate philanthropist.


Mr Simon Dulhunty
Mr Dulhunty is a media professional. After 25 years as a journalist and editor, including running Sydney’s The Sun-Herald for almost four years (2007-2011), Simon is a Director of ASX listed company TopBetta Holdings Ltd Chairman of the Board and trustees of the journalist-supporting Kennedy Foundation.


Mr Simon Ford
Simon is CEO of Intrepid Investment Partners and has previously been an investment banker and asset manager for 35 years with ANZ, Credit Suisse and JP Morgan in Sydney and London. He has held numerous internal board positions in banking and holds an MBA from Chicago, an MSc from the London School of Economics and a Bachelor of Aeronautial Engineering from Sydney.


Mrs Julie Ford
Julie holds a Bachelor of Arts (Economic) from Northwestern University, an MBA from the University of Chicago and a Master of Science (Accounting and Finance) from the London School of Economics. She has worked in roles in banking, advisory, sales and marketing.


Mrs Tanya Jones
Tanya is a communications and advertising professional with over 20 years’ experience. As Managing Director for Lawrence Creative Strategy she worked on many successful corporate and political campaigns, such as Qantas ‘Feels Like Home’ and Kevin07, in partnership with the late Neil Lawrence – Centenary’s inaugural Foundation Chair.


Mr Dominik Mersch
Dominik has had over 10 years’ experience in the arts industry, founding his own gallery, DOMINIK MERSCH GALLERY in Sydney in 2006. He is highly regarded for his management of public, corporate and residential art projects.


Mr Mark Sutton
Bio coming soon.


Mr Andrew White
Bio coming soon.